documents: FDA-2015-D-2818-0044
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2015-D-2818-0044 | FDA | FDA-2015-D-2818 | Rare Diseases: Considerations for the Development of Drugs and Biological Products; Guidance for Industry; Availability | Notice | Notice of Availability | 2023-12-26T05:00:00Z | 2023 | 12 | 2023-12-26T05:00:00Z | 2023-12-26T14:43:28Z | 2023-28310 | 0 | 0 | 0900006486359d43 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref